CVRx's Series E brings in $84mm

CVRx Inc. (developing the Rheos system to control hypertension) has raised $84mm through the closing of its Series E venture round. New Enterprise Associates and Johnson & Johnson Development Corp. co-led the financing and were joined by current backers BBT Fund, Thomas Weisel Healthcare Venture Partners, InterWest Partners, Frazier Healthcare Ventures, and SightLine Partners. The company will use the funds to continue its pivotal trial to gain FDA approval for the Rheos device (it is already CE Marked in Europe) and to build a sales and marketing team prior to launching the product. CVRx has raised over $209mm since it was formed in 2001.